Bacterial artificial chromosomes improve recombinant protein production in mammalian cells

被引:20
|
作者
Blaas, Leander [1 ]
Musteanu, Monica [1 ]
Eferl, Robert [1 ]
Bauer, Anton [2 ]
Casanova, Emilio [1 ]
机构
[1] Ludwig Boltzmann Inst Canc Res LBI CR, A-1090 Vienna, Austria
[2] F Star, A-1230 Vienna, Austria
来源
BMC BIOTECHNOLOGY | 2009年 / 9卷
关键词
ESCHERICHIA-COLI; EXPRESSION; EFFICIENT;
D O I
10.1186/1472-6750-9-3
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: The development of appropriate expression vectors for large scale protein production constitutes a critical step in recombinant protein production. The use of conventional expression vectors to obtain cell lines is a cumbersome procedure. Often, stable cell lines produce low protein yields and production is not stable over the time. These problems are due to silencing of randomly integrated expression vectors by the surrounding chromatin. To overcome these chromatin effects, we have employed a Bacterial Artificial Chromosome (BAC) as expression vector to obtain stable cell lines suitable for protein production. Results: In this work, we explore the efficacy of a Bacterial Artificial Chromosome based vector applied to production of the constant region of the human IgGI. Direct comparison of bulk HEK 293 cell cultures generated with a "conventional" vector or with a BAC-based vector showed that the BAC-based vector improved the protein yield by a factor of 10. Further analysis of stable cell clones harboring the BAC-based vector showed that the protein production was directly proportional to the number of integrated BAC copies and that the protein production was stable for at least 30 passages. Conclusion: Generation of stable cell clones for protein production using Bacterial Artificial Chromosomes offers a clear advantage over the use of conventional vectors. First, protein production is increased by a factor of 10; second, protein production is stable overtime and third, generation of BAC-based expression vectors does not imply a significant amount of work compare to a conventional vector. Therefore, BAC-based vectors may become an attractive tool for protein production.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Bacterial artificial chromosomes improve recombinant protein production in mammalian cells
    Leander Blaas
    Monica Musteanu
    Robert Eferl
    Anton Bauer
    Emilio Casanova
    BMC Biotechnology, 9
  • [2] Artificial chromosomes for mammalian cells
    不详
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1998, 82 (11) : 1230 - 1230
  • [3] Stability of protein production from recombinant mammalian cells
    Barnes, LM
    Bentley, CM
    Dickson, AJ
    BIOTECHNOLOGY AND BIOENGINEERING, 2003, 81 (06) : 631 - 639
  • [4] Production of recombinant protein therapeutics in cultivated mammalian cells
    Wurm, FM
    NATURE BIOTECHNOLOGY, 2004, 22 (11) : 1393 - 1398
  • [5] Production of recombinant protein therapeutics in cultivated mammalian cells
    Florian M Wurm
    Nature Biotechnology, 2004, 22 : 1393 - 1398
  • [6] Delivery of bacterial artificial chromosomes into mammalian cells with psoralen-inactivated adenovirus carrier
    Baker, A
    Cotten, M
    NUCLEIC ACIDS RESEARCH, 1997, 25 (10) : 1950 - 1956
  • [7] Baculovirus recombinant protein production in insect and mammalian cells.
    Kost, Thomas A.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2006, 42 : 2A - 2A
  • [8] Advances in improving mammalian cells metabolism for recombinant protein production
    Altamirano, Claudia
    Berrios, Julio
    Vergara, Mauricio
    Becerra, Silvana
    ELECTRONIC JOURNAL OF BIOTECHNOLOGY, 2013, 16 (03):
  • [9] Multiplexed expression and screening for recombinant protein production in mammalian cells
    Susan DJ Chapple
    Anna M Crofts
    S Paul Shadbolt
    John McCafferty
    Michael R Dyson
    BMC Biotechnology, 6
  • [10] Multiplexed expression and screening for recombinant protein production in mammalian cells
    Chapple, Susan D. J.
    Crofts, Anna M.
    Shadbolt, S. Paul
    McCafferty, John
    Dyson, Michael R.
    BMC BIOTECHNOLOGY, 2006, 6 (1)